Viking Global Equities Master Ltd.'s Net Worth

$1.51 Billion

Estimate Recalculated Feb 28, 2024 07:31PM EST

Who is Viking Global Equities Master Ltd.?

Viking Global Equities Master Ltd. has an estimated net worth of $1.51 Billion. This is based on reported shares across multiple companies, which include Urovant Sciences Ltd., Adaptive Biotechnologies Corp, Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Axovant Gene Therapies Ltd., APi Group Corp, and BridgeBio Pharma, Inc..

SEC CIK

Viking Global Equities Master Ltd.'s CIK is 0001759530

Past Insider Trading and Trends

2019 was Viking Global Equities Master Ltd.'s most active year for acquiring shares with 36 total transactions. Viking Global Equities Master Ltd.'s most active month to acquire stocks was the month of May. 2019 was Viking Global Equities Master Ltd.'s most active year for disposing of shares, totalling 6 transactions. Viking Global Equities Master Ltd.'s most active month to dispose stocks was the month of May. 2022 saw Viking Global Equities Master Ltd. paying a total of $200,000,000.00 for 200,000 shares, this is the most they've acquired in one year. In 2020 Viking Global Equities Master Ltd. cashed out on 8,412,899 shares for a total of $302,143,539.29, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.23%
-1.00M
$55.65
-$55,650,000.00
29.99M
Dec 14
Form 4
-7.46%
-2.50M
$49.52
-$123,787,500.00
30.99M
Nov 11
Form 4
-12.79%
-4.91M
$24.98
-$122,706,039.29
33.49M
Jan 28
Form 4
+2,595.20%
36.98M
$20.00
38.41M
Jul 1
Form 3
0
0
No matching records found

APi Group Corp (APG) Snapshot price: $34.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.90%
-6.50M
$31.30
-$203,450,000.00
27.89M
Jan 2
Form 4
0
0
Jan 3
No matching records found

Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-14.73%
-13.00M
$9.90
-$128,700,000.00
75.24M
Jun 22
Form 3
0
0
No matching records found

Urovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+0.08%
18.2K
$8.32
$151,380.99
22.86M
Scheduled
Jun 17 - Jun 19
Form 4
+0.10%
22.01K
$8.06
$177,300.64
22.84M
Scheduled
Jun 12 - Jun 14
Form 4
+0.09%
21.34K
$8.31
$177,247.38
22.82M
Scheduled
Jun 7 - Jun 11
Form 4
+0.09%
21.12K
$7.86
$165,950.15
22.8M
Scheduled
Jun 4 - Jun 6
Form 4
+0.08%
17.75K
$7.83
$138,946.36
22.78M
Scheduled
May 30 - Jun 3
Form 4
+0.06%
14.48K
$7.63
$110,461.18
22.76M
Scheduled
May 24 - May 29
Form 4
+0.09%
19.83K
$8.22
$162,918.35
22.75M
Scheduled
May 21 - May 23
Form 4
+0.07%
21.61K
$7.63
$162,884.29
31.35M
May 16 - May 20
Form 3
0
0
No matching records found

Myovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 4
+6.32%
2.42M
$8.25
$19,999,996.50
40.77M
Jun 4
Form 3
0
0
No matching records found